FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion

See also
Status	Clinical Trial	Phase
Suspended	`NCT04108481` - Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer	Phase 1/Phase 2
Recruiting	`NCT03562234` - The CLiFF Study: Change in Liver Function and Fat in Pre-operative Chemotherapy for Colorectal Liver Metastases
Recruiting	`NCT03732235` - TACE Associated to Systemic Bevacizumab for the Treatment of Refractory Liver Metastases From Colorectal Cancer
Recruiting	`NCT06126419` - Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration	N/A
Active, not recruiting	`NCT05616039` - I-FIGS Feasibility Study	N/A
Withdrawn	`NCT05175092` - Living Donor Liver Transplantation for CRC Liver Metastases	N/A
Recruiting	`NCT04798898` - Improving Survival of COlorectal LIver Metastases by RFA-mediated Immunostimulation	N/A
Not yet recruiting	`NCT06053996` - Hepatopulmonary Radio-sterilization With Immunotherapy	N/A
Not yet recruiting	`NCT06071052` - TACE Plus HAIC Combined With Regorafenib for Liver Metastasis of Colorectal Cancer Refractory to Standard Treatment Regimens	N/A
Recruiting	`NCT04491929` - Selective Internal Radiation Therapy With 90Y Resin Micropheres for Refractory Colorectal Cancer Liver Metastases
Not yet recruiting	`NCT06050200` - TANGO-LIVER Three Arm Nuclear Growth Observation in Liver Surgery	N/A
Enrolling by invitation	`NCT03444194` - Treatment Response Evaluation in Patients With Non-resectable Colorectal Liver Metastases A Feasibility Study	N/A
Not yet recruiting	`NCT05884723` - Preoperative Ketogenic Diet for Reduction of Hepatic Steatosis	N/A
Not yet recruiting	`NCT06185556` - COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases	Phase 2/Phase 3
Recruiting	`NCT05755672` - On-treatment Biomarkers in Metastatic Colorectal Cancer for Life
Recruiting	`NCT04595266` - Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease	Phase 2
Recruiting	`NCT04701281` - Study of Intra-Arterial Oxaliplatin Plus Capecitabine to Treat Liver Metastases From Colorectal Cancer	Phase 1/Phase 2
Recruiting	`NCT05775146` - SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases	Phase 2
Recruiting	`NCT06200831` - Simultaneous vs. Staged Resection of Colorectal Cancer With Synchronous Liver Metastases	N/A
Active, not recruiting	`NCT04046445` - Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer	Phase 1

NCT number	NCT04832776
Study type	Interventional
Source	Fudan University
Contact	Wenhua Li
Phone	13817922257
Email	whliiris@hotmail.com
Status	Recruiting
Phase	Phase 2
Start date	April 17, 2021
Completion date	December 31, 2025

FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms